retatrutide triple agonist glp-1 gip glucagon phase 2 trial obesity Eli Lilly: GLP-1R/GCGR/GIPR Triagonist Reduces Liver Fat Content by 86% A review of an investigational

10.2215/CJN.0000000624 [DOI] [PMC free article] [PubMed] [Google Scholar] Akarsu S., Gode F., Isik A

Why a Beauty-first Daily Supplement Still Makes Sense Here Heres the honest label-literacy point: L-carnitine is one supporting nutrient, so a daily skin-and-coat formula that already includes it can do double duty

This supplement is especially useful for athletes and active people looking to optimize their physical performance and promote the use of fat as an energy source

This level of efficacy approaches that of sleeve gastrectomy (25-30% at 1 year) and represents a transformative advance in non-surgical obesity treatment